The Anti-Phospholipid Antibodies-IgM test is available at Molecular Diagnostics and Therapy. This blood test detects IgM class antiphospholipid antibodies in order to determine if there is an increased risk of abnormal clotting and complications during pregnancy. The results of this test can be used in conjunction with clinical findings and further investigations to allow for diagnosis of suspected antiphospholipid syndrome (APS).
This blood test detects IgM class antiphospholipid antibodies; depending on the methodology and test requested, this may detect anticardiolipin IgM. This test can detect antiphospholipid antibodies, which may increase the risk of abnormal clotting and complications during pregnancy. This test is often requested as part of a panel of tests to detect antiphospholipid antibodies. This panel may include anticardiolipin IgG and IgM, anti-beta-2 glycoprotein I antibodies, and lupus anticoagulant. Clinical interpretation is required for positive results. To confirm sustained positivity, this test is generally repeated at least 12 weeks after the initial test if indicated by clinical circumstances.
APS is an autoimmune condition, associated with an increased risk of abnormal clotting in arteries and veins, and complications during pregnancy. Antiphospholipid antibodies (IgM class) can be detected with this test. In order for APS to be diagnosed, clinical findings and laboratory findings must be appropriate.
Antiphospholipid antibodies may be associated with abnormal venous clotting. This may include Deep Vein Thrombosis (DVT) and Pulmonary Embolism. This test may be performed in order to determine if there is a risk of venous clotting due to antiphospholipid antibodies.
APS may cause arterial clots. This may lead to complications in patients, including stroke and circulatory problems. This test may be performed as part of an investigation into suspected APS.
Antiphospholipid antibodies are associated with miscarriage and other adverse outcomes in pregnancy. This test may be performed to determine if antiphospholipid antibodies are present as part of a wider clinical investigation.
Antiphospholipid antibodies may be present in patients with autoimmune disorders such as SLE. This test may be requested if clinical symptoms, patient history, or previous laboratory findings indicate a possible antiphospholipid antibody-related disorder.
By providing Radiology, Nuclear Medicine, and Pathology services at the same location, we are able to provide integrated diagnostic services. We carefully manage samples, perform consistent procedures in the laboratory, and perform specialist investigations with quality assurance in order to give reliable diagnostic results. We prioritise clear reporting, reliable laboratory procedures and patient-focused care.
To book the Anti Phospholipid Antibodies-IgM test, contact Molecular Diagnostics and Therapy. Please bring a prescription from your doctor and any relevant clinical information. If available, please also bring any previous reports. This test does not generally require fasting; however, please follow any specific instructions from your doctor or diagnostic centre. If you are taking anticoagulant medication, please inform your doctor. If further testing for lupus anticoagulant is required, this should be taken into consideration.
Test information: Fasting is generally not required.
Reporting: Within 24 hours*